PT88539A - Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen - Google Patents

Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen

Info

Publication number
PT88539A
PT88539A PT88539A PT8853988A PT88539A PT 88539 A PT88539 A PT 88539A PT 88539 A PT88539 A PT 88539A PT 8853988 A PT8853988 A PT 8853988A PT 88539 A PT88539 A PT 88539A
Authority
PT
Portugal
Prior art keywords
proteinen
stabilisierung von
therapeutisch wirksamen
zubereitungen
pharmazeutischen
Prior art date
Application number
PT88539A
Other languages
English (en)
Other versions
PT88539B (pt
Inventor
Traute Mundorf
Kurt Schnecker
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of PT88539A publication Critical patent/PT88539A/pt
Publication of PT88539B publication Critical patent/PT88539B/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/191Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/217IFN-gamma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
PT88539A 1987-09-17 1988-09-16 Processo para a estabilizacao de proteinas com actividade terapeutica em composicoes farmaceuticas PT88539B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873731255 DE3731255A1 (de) 1987-09-17 1987-09-17 Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen

Publications (2)

Publication Number Publication Date
PT88539A true PT88539A (pt) 1988-10-01
PT88539B PT88539B (pt) 1992-11-30

Family

ID=6336244

Family Applications (1)

Application Number Title Priority Date Filing Date
PT88539A PT88539B (pt) 1987-09-17 1988-09-16 Processo para a estabilizacao de proteinas com actividade terapeutica em composicoes farmaceuticas

Country Status (20)

Country Link
EP (1) EP0307857B1 (pt)
JP (1) JP2783552B2 (pt)
KR (1) KR970008112B1 (pt)
AT (1) ATE126063T1 (pt)
AU (1) AU615473B2 (pt)
CA (1) CA1329121C (pt)
DD (1) DD274562A5 (pt)
DE (2) DE3731255A1 (pt)
DK (1) DK516288A (pt)
ES (1) ES2077559T3 (pt)
FI (1) FI95770C (pt)
GR (1) GR3017432T3 (pt)
HU (1) HU203045B (pt)
IE (1) IE70908B1 (pt)
IL (1) IL87778A (pt)
NO (1) NO179436C (pt)
NZ (1) NZ226209A (pt)
PT (1) PT88539B (pt)
RU (1) RU2093145C1 (pt)
ZA (1) ZA886903B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5241925A (en) * 1988-12-27 1993-09-07 Dermamed Apparatus and techniques for administering veterinary medicaments
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
US5130298A (en) * 1989-05-16 1992-07-14 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
US5324521A (en) * 1989-12-18 1994-06-28 Dermamed Systems for transdermal administration of medicaments
JPH0776527A (ja) * 1993-06-28 1995-03-20 Hayashibara Biochem Lab Inc 半固形製剤とその製造方法
RU2132184C1 (ru) * 1998-12-16 1999-06-27 Краснодарская научно-исследовательская ветеринарная станция Способ получения препарата "жироформ-плюс" для лечения и профилактики эндометритов у коров
CA2416169C (en) * 2000-07-14 2008-09-23 Allergan, Inc. Compositions containing therapeutically active components having enhanced solubility
RU2216313C2 (ru) * 2000-12-25 2003-11-20 Савченков Сергей Николаевич Лечебно-профилактическое косметическое средство
RU2188665C1 (ru) * 2001-04-09 2002-09-10 Щербакова Элеонора Григорьевна Противовирусное и антибактериальное средство "интерлизин"
ITMI20031640A1 (it) * 2003-08-08 2005-02-09 Mipharm S P A Base per gel bioadesivi.
CU23432B6 (es) * 2005-11-02 2009-10-16 Ct Ingenieria Genetica Biotech Formulaciones estabilizadas que contienen a los interferones gamma y alfa en proporciones potenciadoras
KR20130091663A (ko) * 2010-05-04 2013-08-19 비스코겔 에이비 키토산 조성물
RU2431489C1 (ru) * 2010-05-25 2011-10-20 Федеральное государственное учреждение "Российский научный центр рентгенорадиологии Федерального агентства по высокотехнологичной медицинской помощи" (ФГУ "РНЦРР Росмедтехнологий") Способ лечения хронических воспалительных заболеваний толстого кишечника
FI3638251T3 (fi) 2017-06-12 2024-04-29 Lakewood Amedex Inc Bisfosfosiinin geeliformulaatioita ja niiden käyttötapoja

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5413223A (en) * 1977-07-01 1979-01-31 Ricoh Co Ltd Printer unit
GB2016015B (en) * 1978-01-22 1982-05-06 Hayashibara Co Method of preparing interferon and preparations containing interferon
JPS5598118A (en) * 1979-01-18 1980-07-25 Hayashibara Takeshi Preparation of type-2 interferon and drug containing the same
FR2513124B1 (fr) * 1981-07-21 1989-11-17 Hayashibara Biochem Lab Production et applications du facteur de lyse des cellules-cibles
CA1190148A (en) * 1981-10-13 1985-07-09 Samuel S. Asculai Interferon-containing compositions
JPS5892622A (ja) * 1981-11-28 1983-06-02 Sunstar Inc インタ−フエロン安定配合製剤
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
JPS5910524A (ja) * 1982-07-08 1984-01-20 Toray Ind Inc インタ−フエロン組成物およびその製造法
JPS6061535A (ja) * 1983-08-24 1985-04-09 エフ・ホフマン・ラ・ロシユ・ウント・コンパニ−・アクチエンゲゼルシヤフト 製薬学的組成物
EP0177342A3 (en) * 1984-10-04 1987-12-02 Genentech, Inc. Oral formulation of therapeutic proteins
DE3603444A1 (de) * 1986-02-05 1987-08-06 Thomae Gmbh Dr K Pharmazeutische zubereitungsformen zur stabilisierung von interferon alpha
US4822605A (en) * 1986-02-18 1989-04-18 Exovir, Inc. Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like

Also Published As

Publication number Publication date
FI884240A0 (fi) 1988-09-15
FI884240L (fi) 1989-03-18
HU203045B (en) 1991-05-28
FI95770B (fi) 1995-12-15
DK516288D0 (da) 1988-09-16
AU2231688A (en) 1989-03-23
JP2783552B2 (ja) 1998-08-06
GR3017432T3 (en) 1995-12-31
HUT47436A (en) 1989-03-28
FI95770C (fi) 1996-03-25
PT88539B (pt) 1992-11-30
JPH01102029A (ja) 1989-04-19
EP0307857B1 (de) 1995-08-09
NO884123D0 (no) 1988-09-16
IE882812L (en) 1989-03-17
NO884123L (no) 1989-03-20
ZA886903B (en) 1990-05-30
CA1329121C (en) 1994-05-03
NO179436B (no) 1996-07-01
DD274562A5 (de) 1989-12-27
EP0307857A1 (de) 1989-03-22
IL87778A (en) 1993-05-13
IL87778A0 (en) 1989-03-31
AU615473B2 (en) 1991-10-03
NZ226209A (en) 1991-06-25
ATE126063T1 (de) 1995-08-15
DE3854290D1 (de) 1995-09-14
RU2093145C1 (ru) 1997-10-20
DK516288A (da) 1989-03-18
KR890004719A (ko) 1989-05-09
ES2077559T3 (es) 1995-12-01
DE3731255A1 (de) 1989-04-06
NO179436C (no) 1996-10-09
KR970008112B1 (ko) 1997-05-21
IE70908B1 (en) 1997-01-15

Similar Documents

Publication Publication Date Title
ATE91903T1 (de) Pharmazeutische kombinationspraeparate und deren verwendung als antineoplastische arzneimittel.
DK483188D0 (da) Stabiliserede humanproteinpraeparater
DK642587A (da) Insulinpraeparat
ATE113650T1 (de) Ausgewählte stämme von lactobacillus enthaltende pharmazeutische zusammensetzungen.
NL930119I1 (nl) Farmaceutische en veterinaire preparaten van cysteine-125-verminderde muteïnen van interleukine-2 ende produktie daarvan
PT88539A (pt) Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen
DE59105808D1 (de) Verwendung von pharmazeutischen und kosmetischen Präparaten mit Mischmicellen.
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
ES2136105T3 (es) Preparacion farmaceutica y/o cosmetica.
DE3875108D1 (de) Physiologisch aktives polypeptid und pharmazeutische komposition.
DE3771611D1 (de) Butensaeure-n-phenylamide mit pharmazeutischen eigenschaften.
ATE56138T1 (de) Perfluorkohlenwasserstoffe als vehikel zur verabreichung von arzneimitteln.
TR199903192T2 (xx) Eritropoetin, de�i�tirilmi� hemoglobin i�eren farmasotik kombine m�stahzarlar.
DK304485A (da) Faste laegemiddelpraeparater med dihydropyridiner samt fremstilling deraf
AU6788687A (en) A pharmaceutical which can be administered nasally, a process for its preparation, and its use
DE3867086D1 (de) Benzothiepino(5,4-c)pyridazin-verbindungen und ihre pharmazeutischen wirkungen.
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
DE3869939D1 (de) Biologisch wirksame peptide.
NO875477D0 (no) Rekombinant alveolaert overflateaktivt protein.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19920506

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20080916